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University of North Carolina at Chapel Hill, Chapel Hill, North CarolinaABSTRACT A clot’s function is to achieve hemostasis by resisting fluid flow. Permeability is the measurement of a clot’s
hemostatic potential. It is sensitive to a wide range of biochemical parameters and pathologies. In this work, we consider the
hydrodynamic phenomenon that reduces the mobility of fluid near the fiber surfaces. This no-slip boundary condition both
defines the gel’s permeability and suppresses nanoparticle diffusion in gel interstices. Here we report that, unlike previous
work where steric effects also hindered diffusion, our system—nanoparticles in fibrin gel—was subject exclusively to hydrody-
namic diffusion suppression. This result enabled an automated, high-throughput permeability assay that used small clot
volumes. Permeability was derived from nanoparticle diffusion using the effective medium theory, and showed one-to-one
correlation with measured permeability. This technique measured permeability without quantifying gel structure, and may
therefore prove useful for characterizing similar materials (e.g., extracellular matrix) where structure is uncontrolled during
polymerization and difficult to measure subsequently. We also report that PEGylation reduced, but did not eliminate, the pop-
ulation of immobile particles. We studied the forces required to pull stuck PEG particles free to confirm that the attachment is
a result of neither covalent nor strong electrostatic binding, and discuss the relevance of this force scale to particle transport
through physiological clots.INTRODUCTIONMeasurements of blood clotting function inform treatment
throughout medicine. Clotting diagnostics are vital both
because hemostasis is essential to health, and because path-
ological clotting, whether hypoactive (as in hemophilia) or
hyperactive (as in cardiovascular disease), is a leading cause
of morbidity and mortality worldwide. A clot’s function is to
resist fluid flow, so a vital measurement of clot quality is
a permeability assay (1), which is sensitive to a wide range
of biochemical parameters (2–7) and pathologies, including
diabetes (8), hemophilia (9), myocardial infarction (heart
attack) (10), in-stent-thrombosis (11), idiopathic venous
thromboembolism (12), and ischemic stroke (13,14). Yet
despite the wealth of targeted research studies that demon-
strate permeability’s relevance, the measurement has not
gained substantial clinical adoption because it is time- and
labor-intensive. In this study we demonstrate that nanopar-
ticle diffusion can serve as a permeability assay that is auto-
mated, multiwell-compatible, and scales to microliter-sized
clot volumes.
Permeability is a measurement of fluid flow through a
bulk material. Miniaturizing the assay leads to a gel physics
question: what microscopic properties or phenomena are
tied to bulk fluid flow through a gel? A natural place to
look is the gel’s structure. Indeed, there is validated theory
for fibrous gels that predicts permeability, captured by the
Darcy constant k, from the fiber diameter df and the volume
fraction f (15). However, precise measurement of clot struc-Submitted February 16, 2011, and accepted for publication June 15, 2011.
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into fiber diameter (16), but cannot measure volume frac-
tion. Extracting clot structure from microscopy techniques
remains an area of active research (17,18).
In fact, gel permeability is less a property of gel structure
than it is a fluid’s interaction with gel structure. The fluid
flowing through the gel is subject to a no-slip boundary
condition that reduces the fluid flow near the fiber surfaces.
To measure this hydrodynamic phenomenon at the micro-
scale, we developed a variation on the techniques of micro-
rheology, in which the Brownian motion of small particles is
used to calculate the bulk storage and loss moduli of the
surrounding material (19–22). Here, we use the effective
medium theory (23) to relate nanoparticle diffusion to
permeability. Prior work has been unable to apply the effec-
tive medium theory without the addition of a term that
depends on gel structure (df and f) (24). We explain the
time- and length-scales over which the effective medium
theory can be applied without correction.
This study, like that of Valentine et al. (25), used com-
mercially available carboxylate-modified polystyrene nano-
particles that we surface-functionalized with 2 kDa
polyethylene glycol (PEG). PEG surface chemistry dramat-
ically reduced—but surprisingly, does not eliminate—the
sticking of particles to the gel. We therefore examined the
forces required to pull ostensibly stuck PEG particles free
from fibrin.Diffusion suppression theory
In considering diffusion of chemically inert spheres in
fibrin, we assume the gel to be a fluid-flooded scaffold ofdoi: 10.1016/j.bpj.2011.06.052
944 Spero et al.rigid rods. The degree of fiber motion depends on the
spacing between fiber junctions and the fiber persistence
length. Junction density varies with clotting conditions;
reports of fiber persistence length have varied by orders of
magnitude depending on the length-scales probed (26–28).
In any case, fiber motion is small relative to the interfiber
spacing.
Sub-mesh-size particles diffusing within this type of
structure are subject to two physical phenomena that hinder
particle motion. The first is hydrodynamic diffusion
suppression, the result of an increased friction coefficient
on the particle due to no-slip boundary conditions at the
fiber surfaces. The second is steric diffusion suppression,
the result of the particle’s physical exclusion from the space
that the fibers occupy. The effects are separable (29),
Deff
D0
¼ FSdf ;f; (1)
where D0 is the diffusion coefficient (30) in buffer and Deff
is the in-gel diffusion coefficient. F captures the hydrody-
namic interaction and S(df, f), the steric; both F and S range
from 0–1.
We hypothesize that the steric interaction occurs only if
the particle diffuses for enough time (and therefore across
enough distance) that the particle encounters many fibers
(Fig. 1). Over short timescales there is no steric interaction
(S(df,f)/ 1), and diffusion is suppressed by hydrodynamic
effects alone (Deff/D0/ F). Hydrodynamic interactions are
created by the same boundary conditions that determine gel
permeability, so that diffusion and permeability may be
related through the effective medium theory (23),
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where d is the particle diameter and k is the Darcy constant
or hydraulic conductivity. Originally proposed in 1989 (23),cba
FIGURE 1 Phenomena that suppress diffusion depend on the timescale
of particle motion, t, and the spacing of the fibers, l. (a) A particle diffusing
over very short timescales samples the fluid locally: the closer the particle is
to the fiber surfaces, the more diffusion is suppressed, so Deff becomes
a function of the particle’s position in space. (b) Over slightly longer time-
scales, the particle samples locations both near and far from the fibers so
that on average the fluid is effectively a uniform medium of lower viscosity.
This is the assumption of the effective medium theory used in this work. (c)
If the particle diffuses for long enough, it will begin colliding with the fibers
(marked by X). These events are steric interactions, and must be accounted
for as in Eq. 1.
Biophysical Journal 101(4) 943–950this theory was tested (24) and shown to inadequately
describe diffusion suppression without the addition of the
steric term S. The steric term was required because particles
diffused across distances of 20 mm in agarose gels with
pores ~10 nm—a pairing of length-scales that ensured
particle collisions with the gel matrix. However, with a suffi-
ciently large fiber-to-fiber spacing or a sufficiently short
distance traveled, diffusion with no steric interactions
should be observable. Fibrin fiber spacings range from
~0.1–10 mm (31), and can therefore accommodate larger
particles. Larger nanoparticles move slower and are easier
to image, so they can be tracked with less sensitive and
higher-bandwidth technology. In this sense, fibrin is espe-
cially convenient as a system to study hydrodynamic diffu-
sion suppression.MATERIALS AND METHODS
Proteins and reagents
Diamine polyethylene glycol (PEG) of molecular mass 2000 Da was
purchased from RAPP Polymere (Tu¨bingen, Germany), 1-ethyl-3-(3-dime-
thylaminopropyl)carbodiimide and hydrochloride from Invitrogen (Carls-
bad, CA), glycine (98%) from Acros Organics (Morris Plains, NJ), and
2-(n-morpholino)ethanesulfonic acid from Sigma-Aldrich (St. Louis,
MO). HEPES buffered saline (HBS) was prepared with n-(2-hydroxyethyl)
piperazine-n0-2-ethanesulfonic acid (Fisher Scientific, Fair Lawn, NJ).
Dulbecco’s phosphate-buffered saline 1 was purchased from GIBCO
(Grand Island, NY). Plasminogen-depleted human fibrinogen and human
a-thrombin were purchased from Enzyme Research Laboratories (South
Bend, IN) and aliquots were stored at –80C.Alexa Fluor-488-labeled fibrinogen
Alexa Fluor 488-labeled fibrinogen from Invitrogen was prepared accord-
ing to the product manual except the starting protein concentration was
4 mg/mL. Labeling yielded 8 mol of dye per mole of protein. Aliquots
stored at –80C were thawed only once before use.Nanoparticle and fibrin clot preparation
Clots were formed at the concentrations indicated by mixing equal volumes
of thrombin and fibrinogen solution in a plasma-cleaned 96-well plate, then
incubated for 2.5 h at room temperature. Fluorescent fibrin gels were
prepared by adding 4% by weight Alexa Fluor 488-labeled fibrinogen.
Di-amine PEG was attached to carboxylate-modified fluorescent micro-
spheres (Invitrogen), then surface modification and size was confirmed by
Zeta-sizer (Malvern Instruments, Malvern, UK), as in existing protocols
(32). (No significant changes in particle size or aggregation were detected
after PEGylation.) Particles were added to the thrombin solution during
preparation at a concentration to yield 20–25 beads per field of view
(number density 108 cm–3). During the same preparation, the reagents
were used to form clots in plastic tubing. After clot formation, tubes
were cut to a fixed length using a razor blade. The tubing was sufficiently
rigid that no deformation was observed, and the clot did not apparently stick
to the side of the razor after cutting. HBS was perfused by gravity feed (total
volume 0.1–1 mL) and flow rate was measured using graduated markings
and a stopwatch. We calculated permeability by the Darcy equation,
_Q ¼ kADP=Lh, where _Q is the flow rate, DP is the pressure gradient across
the clot, h is the HBS viscosity, and A is the tube’s cross section, and L is its
length.
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Clotting time was determined by loading a microplate of similarly prepared
clots into a SpectraMax Plus 384 (Molecular Devices, Sunnyvale, CA)
spectrophotometer. The incubation time for these experiments was taken
to be longer than the longest clotting time of all the clot types.Laser-scanning confocal microscopy
Clots were imaged with an LSM 5 Pascal laser-scanning confocal micro-
scope with an Axiovert 200 M stand, a 63/1.4 NA oil immersion Plan
Apochromatic lens, and LSM 5 software (Carl Zeiss, Oberkochen,
Germany). An argon ion laser at 20% power at 488 nm was used for exci-
tation and a green band-pass filter of 505–530 nm was used for emission.
The pinhole diameter was 1 airy unit, the zoom factor was 1, and the reso-
lution was 1024  1024 pixels for 8-bit images. Optical resolution was
0.14 mm in the x-y plane and 0.5 mm in the z axis. Stacks of 10.09 mm
were captured at a height of 50 mm in each clot using the optimal interval
for Nyquist sampling at 0.32 mm to obtain 33 optical slices. Images area
was 145 mm  145 mm.High-throughput data acquisition and analysis
Clots were formed in 96-well optical-bottom microplates and placed on
a custom-built, inverted wide-field epifluorescence microscope with a
40/0.65 NA air objective (UKA Optics, Oyster Bay, NY), an automated
X-Y stage (Ludl Electronics Products, Hawthorne, NY), a Flea2 camera
(Point Gray Research, Richmond, British Columbia, Canada), and
custom-controlled software. Videos of particle diffusion were recorded at
20 frames/s for 12 s at 13 different locations in each well. Particle tracking
was performed automatically using custom-designed CISMM Video Spot-
Tracker v5.29 (http://www.cismm.org/downloads/). Particle trajectories
were filtered to eliminate tracks that lasted <2 s.
A programmatic analysis pipeline was developed using the MATLAB
programming environment (The MathWorks, Natick, MA). In homogenous
but viscoelastic materials, particle diffusion is suppressed on certain time-
scales such that 
r2

a ta; (3)
where 0 < a < 1 (33). The power-law a may not be constant over all time-
scales. However, for any range of t over which a ¼ 1, the motion is classic
diffusion, such that (in two dimensions)
r2
 ¼ 4Dt; (4)
where hr2i is the time-averaged squared displacement over a given lag time
t, and D is the diffusion coefficient. For particle tracks in which 0.8 < a <
1.2, we calculated D for each track by averaging D¼ hr2i/4t for all t< 1 s.0 0.5 1 1.5
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size and plot the average hr2i for both populations of each type of bead. Freely
with a < 0.2. Note that there is no freely diffusing population of 1-mm particleDiffusion simulation
To test the fidelity of our software algorithms, we implemented a random
walk generator that took a fluid viscosity (h0 ¼ 103), temperature (T ¼
297 K), particle size (d ¼ 228 nm), and time interval between steps t ¼
1/20 s. It generated two pseudo-random sequences of step sizes that were
normally distributed about zero, integrated to calculate positions x(t),
y(t), then scaled to real units by the input parameters as defined by Eq. 4.
This simulated particle trace was then processed using the same analysis
pipeline as the real particle traces (Fig. 2).Statistical methods
For measurements ofDeff we calculated the 95% confidence interval (equiv-
alent to a p-value of 0.05) s95 ¼ 1:96
. ﬃﬃﬃﬃ
N
p ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
D
2
i  D2i
q
, where Di is the Deff
calculated for each tracker. This 95% confidence interval was plotted as
vertical error bars in Figs. 3 and 4. Similar processing was used to deter-
mine confidence intervals for permeability, plotted as horizontal error
bars in Fig. 4.Magnetic force application
Driven microrheometry measurements were performed on fibrin gels using
a recently described multiforce high throughput system (34). Super-para-
magnetic 2.8 mm particles (Invitrogen) were functionalized with PEG
and mixed with varying concentrations of fibrinogen, as described above.
Fibrin gels with suspended particles were formed in a magnetic
microplate.
The magnetic drive sequence began with a de-Gauss (a rapidly decaying
force profile that eliminates remanent magnetization—see Spero et al.
(34)), followed by three pulses. Many PEG particles traveled all the
way across the field of view to collide with the pole tip, causing tracks
to end early. Due to the erratic motion of the particles, videos were deci-
mated from 120 Hz to 4 Hz to enable hand-tracking of particles using
the Manual Tracking plug-in for ImageJ (National Institutes of Health,
Bethesda, MD). The error in this method is ~d(1/3) ¼ 5 1 mm. Net
displacement was defined as the distance between a particle’s first and
last recorded positions. For particles that entered from outside the field
of view, the initial position was taken to be the position at which the
particle entered the field.RESULTS
Nanoparticle diffusion in fibrin is bimodal
Using an automated video microscopy system, we measured
diffusion of thousands of PEG-functionalized nanoparticles100 101
(s)
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FIGURE 2 Nanoparticle diffusion in fibrin is
bimodal, while microparticles get stuck. (a) From
diffusion measurements of three particle sizes
(0.2, 0.5, and 1 mm) in gels formed with 1 mg/mL
fibrinogen and 10 nM thrombin, we generate
a histogram of the hr2i power-law a. Particles in
fibrin (B) fall into two populations: freely
diffusing (a/ 1) and stuck (a/ 0). To verify
that the observation of free and stuck populations
was not an artifact of bead tracking or analysis
algorithms, we compared our data with measure-
ments on particles diffusing in buffer (C) and
b) We separate and average the stuck and free population for each particle
diffusing particles are those with 0.8 < a < 1.2. Stuck particles are those
s.
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FIGURE 3 Nanoparticle diffusion is suppressed by fibrin gel. Comparing confocal microscopy (scale bar is 20 mm) of fibrin with particle diffusion shows
that the size-scaled diffusion coefficient dDeff is sensitive to fibrin gel structure. The spacing between fibers can vary widely among clots of varying type, from
0.1–10 mm (31). Our clot imaging (Fig. 3) show fiber spacings across a similarly wide range. (a) Diffusion under varying fibrinogen concentration (thrombin
concentration 10 nM).Deff of 526 nm particles (solid) diverges from buffer value (0 mg/mL fibrinogen) with increasing fibrinogen concentration. The smaller
(228 nm) particles’ diffusion (dash-dot) is also suppressed by the gel, but is less sensitive to the changes in gel structure. (b) A similar effect occurs with 228-
nm and 526-nm particles under varying thrombin concentration (fibrinogen concentration 1 mg/mL). (Dashed line in both graphs) Theoretical prediction of
dDeff for a sphere diffusing in water. In a homogeneous material, the quantity dDeff for two particles of different sizes is expected to be invariant. As this is not
the case, nanoparticles of different sizes experience effectively different viscosities. Number of trackers N > 150 for each data point. On average, N ¼ 480.
Bars show 95% confidence intervals.
946 Spero et al.(diameters d ¼ 0.228, 0.526, and 1 mm) and examined their
mean-squared displacements hr2i f ta. We observed two
populations of power laws a, as seen earlier in Fig. 2.
Most particles diffused freely (a / 1), as if in a purely
viscous fluid. The remaining particles had a lower power-
law dependence (a/ 0) indicative of a stuck particle. As
expected, the particles diffusing in buffer and the simulated
random walks both exhibited a/ 1.Nanoparticle diffusion depends on clot structure
To determine how free particle diffusion responds to the pres-
ence of a fibrin gel, we tested a range of purified gel types:
from low to high thrombin concentration (1–30 nM); from
low to high fibrinogen concentration (0.5–3 mg/mL); and
with the two particle sizes (d ¼ 228 and 526 nm). In each
type of clot, and for each particle size, we captured on
average 690 particle tracks, 480 of which were freely
diffusing. Representative confocal microscopy of the clots
is shown in Fig. 3. From the freely diffusing particle traces
(a/ 1), we calculated Deff. At least 150 freely diffusing
particles were used to calculate each datapoint. The number
of particles in the measurement is the dominant parameter in
defining the confidence bars in Fig. 3.
We considered the measured diffusion coefficient scaled
by the particle diameter, dDeff. According to Stokes-
Einstein theory, this value should collapse to a common
value for particles of different sizes in buffer,Biophysical Journal 101(4) 943–950dD0 ¼ kBT
3ph0
; (5)
where h0 is the viscosity of buffer and kBT is the thermal
energy. Fig. 3 shows that only in buffer was dDeff invariant
with bead size. As both fibrin density and thrombin concen-
tration increased, the 526-nm particles saw greater frac-
tional diffusion suppression than the 228-nm particles,
implying that differently sized particles experience environ-
ments of different effective viscosities.Diffusion at short timescales measures bulk
permeability
To better understand the diffusion suppression reported in
Fig. 3, we explicitly tested the effective medium theory
(Eq. 2) by measuring gel permeability k (Table 1). Clot
permeabilities were in the expected range for purified
clots—for example, see Blomba¨ck and Okada (1). As ex-
pected, the permeability dropped with increasing thrombin
and fibrinogen concentrations.
We compare our results with the effective medium theory
in Fig. 4. The data points show excellent agreement with the
theory, plotted as lines. Note that the data are plotted inde-
pendent of the theory; namely, no fitting was performed
to assemble Fig. 4. This result strongly implies that on these
length- and timescales, hydrodynamic effects alone
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FIGURE 4 Nanoparticle diffusion in fibrin
measures bulk permeability through the effective
medium theory. Our data (, B) for Deff and k
overlay the effective medium theory (dash-dot
and solid lines), without fitting parameters.
(Horizontal and vertical bars) 95% confidence
intervals. (Inset) The effective medium theory
can be used to calculate clot permeability from
a small-volume, high throughput diffusion assay.
We derive kEM from Deff and see one-to-one corre-
spondence for 0.2 () and 0.5 mm (B) particles.
Also shown is kEM (C) derived using a technique
that is agnostic to the background viscosity (Eq. 6).
Particle Diffusion Measures Permeability 947suppress nanoparticle diffusion in fibrin, as we hypothesized
in our introduction of Eq. 1. Hydrodynamic diffusion sup-
pression also explains the reason for the difference in rela-
tive suppression of 526-and 228-nm particles in Fig. 3: on
average, the surface of the larger particles is closer to the
gel matrix, where the fluid is less mobile and the resistance
to motion greater. We are not aware of another polymer gel
system in which this condition has been shown to hold true.
According to Eq. 2, Deff is determined both by the gel
(through k) and the viscosity and temperature of the solvent
(through D0 (30)). In purified fibrinogen clots, the solvent
viscosity is well controlled, but this is not the case in plasma
or whole blood clots, where the viscosity is typically 2- to
100-fold hH20 (35). The solvent viscosity could be measured
by eluting the solvent from the clot and measuring its
viscosity independently, but this is impractical in a high-
throughput protocol. We factored out the temperature and
solvent viscosity by calculating the ratio Dd¼526/Dd¼228
for each clot type, then derived permeability using the
relation
Dd1
Dd2
¼ d2
d1
12kþ 6d2
ﬃﬃ
k
p þ d22
12kþ 6d1
ﬃﬃ
k
p þ d21
: (6)
Fig. 4 shows one-to-one correlation between the Darcy
constant calculated from the effective medium theory (kEM)
and the Darcy constant measured by gel perfusion (kperm).TABLE 1 Summary of permeability measurements
Fibrinogen (mg/mL) Thrombin (nM) k (mm2)
0.5 10 50
1 1 2.4
1 5 0.55
1 10 0.48
1 30 0.30
2.7 10 0.18
2 30 0.12
3 30 0.10Stuck particles pull free under applied force
It was surprising that some particles, even after PEG func-
tionalization, did not freely diffuse. To explore the reason
for this sticking, we used a magnetic force system (34) to
apply forces to particles. We used 2.8-mm PEG and
COOH particles, which, as with the 1-mm particles studied
above, did not freely diffuse. Because COOH particles stick
to fibrin, they oscillated back and forth as the force was
turned on and off, but ultimately traveled short distances
(0–26 mm). Some PEG particles, by contrast, jumped
through the matrix of the gel, traveling as much as 65 mm
in even the least permeable clots. Some PEG particles,
however, did not travel long distances. In short, PEG surface
chemistry increased microparticle mobility, but PEG
particle behavior was heterogeneous and highly unpredict-
able. Videos of the driven particle experiments are available
in Movie S1 in the Supporting Material.
The net travel of PEG particles as compared with COOH
particles are shown in Fig. 5. The mean distances traveled
by PEG particles as reported in Fig. 5 were lower
bounds, because 31% (3 mg/mL fibrinogen clots) to 44%
(0.5 mg/mL fibrinogen) of particles entered the field of
view from off-screen while the forces were being applied.
By contrast, no COOH particles entered the field of view
during the pulling except in the clots formed with the least
fibrinogen, in which 11% of particles entered from off-
screen.
From these data we can deduce the force required to
disrupt the stuck-state of PEG particles in fibrin gel. The
force applied by this magnetics system is highest at the
edge of the pole tip; the farther the particle from the tip,
the lower the applied force. The force at the pole tip was
2 nN; at the edge of the field of view (~150 mm from the
pole tip) the force was 0.1 nN. Therefore, forces of <100
pN can disrupt the stuck state of the particles such that
they may move long distances through the gel. Thus,
although PEGylated micron-scale particles do not freelyBiophysical Journal 101(4) 943–950
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FIGURE 5 PEG microparticles (d ¼ 2.8 mm)
can be forced through fibrin gels at forces found
in physiological blood flow. Magnets were de-
Gaussed (see Spero et al. (34)), then pulsed three
times, applying forcesR100 pN. (See Discussion
for physiological relevance of this force scale.) (a)
COOH microparticle trajectories r(t) in clots pre-
pared from 3 mg/mL fibrinogen, 10 nM thrombin.
Without PEGylation, particles have a homoge-
neous, elastic force response: particles advance
when the force is applied (shaded region) and
retract when the force is turned off. (b) PEG micro-
particle trajectories r(t) in clots prepared from
3 mg/mL fibrinogen, 10 nM thrombin. Small
forces (R100 pN) break the stuck state of some
PEG particles so that they jump long distances
through the gel and do not retract to their original
location. Some PEG particle tracks end early
because the particles collide with the pole tip.
The force response of PEG particles is heteroge-
neous: some do not travel long distances, which
we attribute to physical entrapment of the particles
in the gel. (c) Scatter plot showing net displacement of 2.8 mm PEG particles (B) and COOH particles (*) after three pulses. Across clot types, there is
a highly mobile population of PEG particles that does not exist for COOH particles. However, particle travel is widely scattered, suggesting a heterogeneous
environment. (Lines) Average particle travel, for reference. Number of COOH particles N¼ 9, 10, and 11 and number of PEG particles N¼ 39, 10, and 13 for
0.5, 1, and 3 mg/mL fibrinogen, respectively.
948 Spero et al.diffuse in fibrin gels, they can be forced through the matrix
at low force.DISCUSSION
Diffusion measures permeability in high
throughput
We have demonstrated a fully automated assay (see Mate-
rials and Methods) that measures Deff and shown its utility
as a single-parameter indicator of clot structure. Moreover,
this diffusion coefficient can be used to calculate clot
permeability through the effective medium theory. The
myriad biochemical factors and pathological conditions
that can affect clot structure speak to the need for effective
tools to measure clot structure in high throughput. In partic-
ular, a high throughput permeability assay would enable
small molecule or protein library screens to develop drugs
that specifically target modification of clot permeability.
Nanoparticle-determination of permeability enables
considerable labor and time savings over a permeability
measurement. Each clot measurement in this work is based
on thirteen 12-s videos, or 2.6 min per clot type. For a
96-well microplate, this represents 4.2 h of unattended
data collection. By contrast, 96 permeability measurements
would require 72–120 h of manual data collection, not
including time required to exchange samples. In addition,
the diffusion assay is microplate-compatible, so sample
preparation and tray handling could also be automated.
Fig. 4 shows that the perfusion measurement of perme-
ability is more sensitive than the calculated method. TheBiophysical Journal 101(4) 943–950former varies by a factor of 20 whereas the latter varies
by a factor of 1.6. The calculated method, therefore, is
best suited to high throughput screening studies, in which
the faster diffusion method can identify leads for subse-
quent, detailed study. The measurement sensitivity is a
concern if the scatter of kEM for one clot type varied more
than the separation between kEM for two different clot types.
Therefore, if greater sensitivity is required for such screens,
the high throughput compatibility of the diffusion method
enables measurements of multiple clots of each type to
better distinguish close clusters. We also note that the calcu-
lated method could potentially reveal microscale heteroge-
neity of permeability within a clot or provide an in vivo
characterization where pressure measurements across the
clot would be difficult.
Regarding the short-timescale constraint for this assay:
Fig. 1 a suggests that measuring particle diffusion on very
short timescales would reveal spatial variation in Deff. In
our data we did not see any evidence of this effect because
the interfiber spacing l was typically <1 mm and Deff was
~1 mm2/s, meaning spatial variations arise only for t <<
1 s, and this work used 0.05 < t < 1 s. Hence, our data
averages over the spatial variations in fluid mobility, as
shown in Fig. 1 b. However, the suppression in both Fig. 1
a and b is due to the same hydrodynamic phenomenon, so
this analysis should hold even if data from a shorter t are
used, provided that a statistically satisfactory population is
gathered. By contrast, diffusion over long timescales would
reveal additional diffusion suppression due to steric effects,
and this would complicate efforts to extract permeability
from particle diffusion.
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Pulling on magnetic microbeads in fibrin revealed that
forces <100 pN were adequate to break the stuck state of
some PEG particles. By comparison, a typical covalent
bond might require 1 eV/1 A˚ ¼ 16 pN to rupture, and an
ionic bond, 1 eV/1 nm¼ 160 pN. Our results strongly imply
that covalent and strong electrostatic interactions—which
the PEG particle surface was intended to minimize—are
indeed blocked.
What, then, immobilizes a PEG particle in a clots? Poten-
tial mechanisms include physical entrapment, weak electro-
static interactions, or stochastic effects such as depletion
flocculation. We believe these questions mark out fertile
ground for discovery, and remain especially relevant in
microrheology, where PEG functionalization has become
an accepted technique for minimizing particle-polymer
interaction.
Finally, our results provide some insight into issues of
drug vector design. There are circumstances—most promi-
nently, in fibrinolytic therapy—in which a drug must be
delivered to or through a clot. Adding PEG to the surface
of a drug vector should improve the vector’s mobility. How-
ever, the existence of a stuck population in these experi-
ments underscores that the physical picture for drug vector
delivery through clots is not complete. The scatter in the
microparticle transport under applied force (Fig. 5 c) shows
that some particles are easier to pull free than others, with
the minimum rupture force<100 pN. According to Stokes’s
Law, a particle in water experiences a 100-pN force at a flow
rate of v< 4 cm/s (36). The higher viscosity of blood further
reduces the required flow rate to v ¼ 0.04–2 cm/s. Arterial
flow rates are ~75–110 mL/min (37), which for a typical
artery lumen diameter of 4 mm (38) corresponds to a fluid
velocity of 10–15 cm/s.
This result suggests that whatever the reason for the asso-
ciation between stuck PEG particles and fibrin in vitro, freely
flowing blood may be able to prevent it in vivo. By contrast,
an occlusive, low-permeability arterial clot (k ~ 1013 m2,
DP ~ 50 mmHg), implies fluid velocities v ~1 mm/s, suggest-
ing that in such clots PEG microparticles could become
attached to fibrin and not be dislodged by perfusion. These
results highlight the need for further research into the impact
of drug vector size and surface chemistry on drug delivery
through clots, both in microfluidic and animal models.SUPPORTING MATERIAL
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